BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sever B, Türkeş C, Altıntop MD, Demir Y, Akalın Çiftçi G, Beydemir Ş. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Arch Pharm (Weinheim) 2021;:e2100294. [PMID: 34569655 DOI: 10.1002/ardp.202100294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Türkeş C, Demir Y, Biçer A, Cin GT, Gültekin MS, Beydemir Ş. Exploration of Some Bis‐Sulfide and Bis‐Sulfone Derivatives as Non‐Classical Aldose Reductase İnhibitors. ChemistrySelect 2023;8. [DOI: 10.1002/slct.202204350] [Reference Citation Analysis]
2 Yakan H, Muğlu H, Türkeş C, Demir Y, Erdoğan M, Çavuş MS, Beydemir Ş. A novel series of thiosemicarbazone hybrid scaffolds: Design, Synthesis, DFT studies, metabolic enzyme inhibition properties, and molecular docking calculations. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.135077] [Reference Citation Analysis]
3 Altıntop MD, Demir Y, Türkeş C, Öztürk RB, Cantürk Z, Beydemir Ş, Özdemir A. A new series of hydrazones as small-molecule aldose reductase inhibitors. Arch Pharm (Weinheim) 2023;:e2200570. [PMID: 36603162 DOI: 10.1002/ardp.202200570] [Reference Citation Analysis]
4 Kakakhan C, Türkeş C, Güleç Ö, Demir Y, Arslan M, Özkemahlı G, Beydemir Ş. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase. Bioorg Med Chem 2023;77:117111. [PMID: 36463726 DOI: 10.1016/j.bmc.2022.117111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Demir Y, Türkeş C, Küfrevioğlu Öİ, Beydemir Ş. Molecular Docking Studies and the Effect of Fluorophenylthiourea Derivatives on Glutathione-Dependent Enzymes. Chem Biodivers 2023;20:e202200656. [PMID: 36538730 DOI: 10.1002/cbdv.202200656] [Reference Citation Analysis]
6 Demir Y, Türkeş C, Çavuş MS, Erdoğan M, Muğlu H, Yakan H, Beydemir Ş. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Arch Pharm (Weinheim) 2022;:e2200554. [PMID: 36575148 DOI: 10.1002/ardp.202200554] [Reference Citation Analysis]
7 Türkeş C, Demir Y, Beydemir Ş. In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202204050] [Reference Citation Analysis]
8 Ertano BY, Demir Y, Nural Y, Erdoğan O. Investigation of The Effect of Acylthiourea Derivatives on Diabetes‐Associated Enzymes. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202204149] [Reference Citation Analysis]
9 Demirci Ö, Tezcan B, Demir Y, Taskin-tok T, Gök Y, Aktaş A, Güzel B, Gülçin İ. Acetylphenyl-substituted imidazolium salts: synthesis, characterization, in silico studies and inhibitory properties against some metabolic enzymes. Mol Divers 2022. [DOI: 10.1007/s11030-022-10578-3] [Reference Citation Analysis]
10 Yararli K, Ozer EB, Bayindir S, Caglayan C, Turkes C, Beydemir S. The synthesis, biological evaluation and in silico studies of asymmetric 3,5-diaryl-rhodanines as novel inhibitors of human carbonic anhydrase isoenzymes. Journal of Molecular Structure 2022. [DOI: 10.1016/j.molstruc.2022.134783] [Reference Citation Analysis]
11 Çalışkan B, Demir Y, Türkeş C. Ophthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studies. Biotechnol Appl Biochem 2022;69:2273-83. [PMID: 34786760 DOI: 10.1002/bab.2284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
12 Demirci Ö, Tezcan B, Demir Y, Taskin-tok T, Gök Y, Aktaş A, Güzel B, Gülçin İ. Acetylphenyl-Substituted Imidazolium Salts: Synthesis, Characterization, in silico Studies and Inhibitory Properties against Some Metabolic Enzymes.. [DOI: 10.21203/rs.3.rs-2161155/v1] [Reference Citation Analysis]
13 Demir Y, Tokalı FS, Kalay E, Türkeş C, Tokalı P, Aslan ON, Şendil K, Beydemir Ş. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors. Mol Divers. [DOI: 10.1007/s11030-022-10526-1] [Reference Citation Analysis]
14 Muhammad Ghali U, Teralı K, Dalmızrak Ö, Özer N. Rethinking common solvents in butyrylcholinesterase activity assays. Inorganic Chemistry Communications 2022;143:109796. [DOI: 10.1016/j.inoche.2022.109796] [Reference Citation Analysis]
15 Korkmaz IN, Türkeş C, Demir Y, Öztekin A, Özdemir H, Beydemir Ş. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors. J Biochem Mol Toxicol 2022;:e23180. [PMID: 35916346 DOI: 10.1002/jbt.23180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Özaslan MS, Sağlamtaş R, Demir Y, Genç Y, Saraçoğlu İ, Gülçin İ. Isolation of Some Phenolic Compounds from Plantago subulata L. and Determination of Their Antidiabetic, Anticholinesterase, Antiepileptic and Antioxidant Activity. Chem Biodivers 2022;:e202200280. [PMID: 35796520 DOI: 10.1002/cbdv.202200280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Korkmaz IN, Türkeş C, Demir Y, Özdemir H, Beydemir Ş. Methyl benzoate derivatives: in vitro Paraoxonase 1 inhibition and in silico studies. J Biochem Mol Toxicol 2022;:e23152. [PMID: 35708184 DOI: 10.1002/jbt.23152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Honglin D, Xiaojie S, Lingling C, Hao W, Chao G, Zhengjie W, Limin L, Jiajie M, Fuqiang Y, Hongmin L, Yu K, Qiurong Z. Synthesis and Antitumor Activity Evaluation of 2,4,6-Trisubstituted Quinazoline Derivatives Containing Thiazole Structure. Chinese Journal of Organic Chemistry 2022;42:3853. [DOI: 10.6023/cjoc202205028] [Reference Citation Analysis]